Amazon cover image
      Image from Amazon.com
      Image from Google Jackets

      Antibody-Drug Conjugates [electronic resource] : The 21st Century Magic Bullets for Cancer / edited by Jeffrey Wang, Wei-Chiang Shen, Jennica L. Zaro.

      Contributor(s): Material type: TextTextSeries: AAPS Advances in the Pharmaceutical Sciences Series ; 17Publisher: Cham : Springer International Publishing : Imprint: Springer, 2015Description: X, 252 p. 59 illus., 32 illus. in color. online resourceContent type:
      • text
      Media type:
      • computer
      Carrier type:
      • online resource
      ISBN:
      • 9783319130811
      Subject(s): Additional physical formats: Printed edition:: No titleDDC classification:
      • 615.19 23
      LOC classification:
      • RS380
      • RS190-210
      Online resources:
      Contents:
      1 Antibody-Drug Conjugates: A Historical Review -- 2 Payloads of Antibody-Drug Conjugates -- 3 Selecting an Optimal Antibody for Antibody-Drug Conjugate Therapy -- 4 Linker Design for Antibody-Drug Conjugates -- 5 Formulation Development for Antibody-Drug Conjugates -- 6 Bioanalytical Assay for Characterization of Antibody Drug Conjugates -- 7 Pharmacokinetics/Pharmacodynamics and Disposition of Antibody-Drug Conjugates -- 8 Regulatory Considerations -- 9 Major ADC Companies, Current Clinical Trials, Recent Patents Issued and Patent Applications, and Cost Analysis of Drug Therapy -- 10 Mylotarg: Revisiting its Clinical Potential Post-Withdrawal -- 11 ADCETRIS: A Regulatory Case Study of a New Generation Antibody Drug Conjugate -- 12 Ado-Trastuzumab Emtansine -- 13 The Antibody-Drug Conjugate Glembatumumab Vedotin (CDX-011) and its Use in Treatment of Breast Cancer -- 14 Summary and Future Directions.
      In: Springer eBooksSummary: This authoritative volume provides a holistic picture of antibody-drug conjugates (ADCs). Fourteen comprehensive chapters are divided into six sections including an introduction to ADCs, the ADC construct, development issues, landscape, IP and pharmacoeconomics, case studies, and the future of the field. The book examines everything from the selection of the antibody, the drug, and the linker to a discussion of developmental issues such as formulations, bio-analysis, pharmacokinetic-pharmacodynamic relationships, and toxicological and regulatory challenges. It also explores pharmacoecomonics and intellectual properties, including recently issued patents and the cost analysis of drug therapy. Case studies are presented for the three ADCs that have received FDA approval: gemtuzumab ozogamicin (Mylotarg®), Brentuximab vedotin (Adcetris®), and ado-trastuzumab emtansine (Kadcyla®), as well as an ADC in late-stage clinical trials, glembatumumab vedotin (CDX-011). Finally, the volume presents a perspective by the editors on the future directions of ADC development and clinical applications. Antibody-Drug Conjugates is a practical and systematic resource for scientists, professors, and students interested in expanding their knowledge of cutting-edge research in this exciting field.
      Tags from this library: No tags from this library for this title. Log in to add tags.
      Star ratings
          Average rating: 0.0 (0 votes)
      Holdings
      Item type Current library Call number URL Status Notes Date due Barcode
      e-Books e-Books SARVAJNA LIBRARY, UHS, BAGALKOT 615.19 (Browse shelf(Opens below)) Link to resource Available Click on the URL to access eBook EB159

      1 Antibody-Drug Conjugates: A Historical Review -- 2 Payloads of Antibody-Drug Conjugates -- 3 Selecting an Optimal Antibody for Antibody-Drug Conjugate Therapy -- 4 Linker Design for Antibody-Drug Conjugates -- 5 Formulation Development for Antibody-Drug Conjugates -- 6 Bioanalytical Assay for Characterization of Antibody Drug Conjugates -- 7 Pharmacokinetics/Pharmacodynamics and Disposition of Antibody-Drug Conjugates -- 8 Regulatory Considerations -- 9 Major ADC Companies, Current Clinical Trials, Recent Patents Issued and Patent Applications, and Cost Analysis of Drug Therapy -- 10 Mylotarg: Revisiting its Clinical Potential Post-Withdrawal -- 11 ADCETRIS: A Regulatory Case Study of a New Generation Antibody Drug Conjugate -- 12 Ado-Trastuzumab Emtansine -- 13 The Antibody-Drug Conjugate Glembatumumab Vedotin (CDX-011) and its Use in Treatment of Breast Cancer -- 14 Summary and Future Directions.

      This authoritative volume provides a holistic picture of antibody-drug conjugates (ADCs). Fourteen comprehensive chapters are divided into six sections including an introduction to ADCs, the ADC construct, development issues, landscape, IP and pharmacoeconomics, case studies, and the future of the field. The book examines everything from the selection of the antibody, the drug, and the linker to a discussion of developmental issues such as formulations, bio-analysis, pharmacokinetic-pharmacodynamic relationships, and toxicological and regulatory challenges. It also explores pharmacoecomonics and intellectual properties, including recently issued patents and the cost analysis of drug therapy. Case studies are presented for the three ADCs that have received FDA approval: gemtuzumab ozogamicin (Mylotarg®), Brentuximab vedotin (Adcetris®), and ado-trastuzumab emtansine (Kadcyla®), as well as an ADC in late-stage clinical trials, glembatumumab vedotin (CDX-011). Finally, the volume presents a perspective by the editors on the future directions of ADC development and clinical applications. Antibody-Drug Conjugates is a practical and systematic resource for scientists, professors, and students interested in expanding their knowledge of cutting-edge research in this exciting field.

      There are no comments on this title.

      to post a comment.
      External Imp. Links

      UHSB || ICAR || IDEAL: A Union Catalog of NARS Libraries || KrushiKosh (Digital Library) || Kanaja (ಕಣಜ – ಕನ್ನಡ ಜ್ಞಾನಕೋಶ) || Karnataka Gazetteer || ASRB || Employment News || ಉದ್ಯೋಗ ಮಾಹಿತಿ || || Karnataka Digital Public Library ||


      For more Information please contact Librarian @ Sarvajna Library, UHS, Bagalkot OR Dr. Gireesh A Ganjihal Assistant Librarian
      "Healthy Soils for a Healthy Life"

      page counter